Antonio Finelli

19.7k total citations
477 papers, 11.2k citations indexed

About

Antonio Finelli is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Antonio Finelli has authored 477 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 348 papers in Pulmonary and Respiratory Medicine, 138 papers in Surgery and 118 papers in Molecular Biology. Recurrent topics in Antonio Finelli's work include Prostate Cancer Diagnosis and Treatment (162 papers), Renal cell carcinoma treatment (155 papers) and Prostate Cancer Treatment and Research (148 papers). Antonio Finelli is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (162 papers), Renal cell carcinoma treatment (155 papers) and Prostate Cancer Treatment and Research (148 papers). Antonio Finelli collaborates with scholars based in Canada, United States and United Kingdom. Antonio Finelli's co-authors include Neil Fleshner, Michael A.S. Jewett, Andrew Evans, Alexandre R. Zlotta, Inderbir S. Gill, Girish S. Kulkarni, Shabbir M.H. Alibhai, Jaimin R. Bhatt, Mihir Desai and Jihad Kaouk and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Antonio Finelli

451 papers receiving 11.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Antonio Finelli 7.4k 3.6k 3.3k 1.8k 1.4k 477 11.2k
Christopher J. Kane 9.4k 1.3× 2.3k 0.6× 2.6k 0.8× 2.9k 1.6× 1.6k 1.2× 423 13.2k
Adam S. Kibel 8.7k 1.2× 3.3k 0.9× 4.6k 1.4× 3.4k 1.9× 2.6k 1.9× 605 15.9k
Axel S. Merseburger 9.6k 1.3× 5.9k 1.7× 4.1k 1.2× 2.5k 1.4× 2.6k 1.9× 421 14.3k
James M. McKiernan 5.1k 0.7× 4.3k 1.2× 4.7k 1.4× 2.1k 1.2× 1.6k 1.1× 340 10.6k
Michael A.S. Jewett 8.9k 1.2× 6.5k 1.8× 6.1k 1.9× 2.0k 1.1× 2.5k 1.8× 418 15.7k
Maxine Sun 9.8k 1.3× 3.1k 0.9× 6.4k 2.0× 3.3k 1.9× 1.6k 1.1× 435 15.8k
Robert Huddart 5.6k 0.8× 2.7k 0.8× 7.8k 2.4× 3.2k 1.8× 910 0.7× 388 14.9k
Martin G. Sanda 10.2k 1.4× 4.7k 1.3× 2.4k 0.7× 3.9k 2.2× 2.0k 1.5× 268 17.6k
Quoc‐Dien Trinh 8.1k 1.1× 2.1k 0.6× 5.2k 1.6× 3.6k 2.1× 1.0k 0.7× 558 14.7k
Stacy Loeb 9.1k 1.2× 1.5k 0.4× 2.4k 0.7× 2.3k 1.3× 1.3k 0.9× 443 13.3k

Countries citing papers authored by Antonio Finelli

Since Specialization
Citations

This map shows the geographic impact of Antonio Finelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Finelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Finelli more than expected).

Fields of papers citing papers by Antonio Finelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Finelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Finelli. The network helps show where Antonio Finelli may publish in the future.

Co-authorship network of co-authors of Antonio Finelli

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Finelli. A scholar is included among the top collaborators of Antonio Finelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Finelli. Antonio Finelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ghai, Sangeet, Antonio Finelli, Katherine Lajkosz, et al.. (2024). MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial. Radiology. 310(3). e231473–e231473. 10 indexed citations
3.
4.
Lajkosz, Katherine, et al.. (2023). Quantitative and qualitative impact of physician assistants in a Canadian urology setting. Canadian Urological Association Journal. 17(10). 337–340. 2 indexed citations
5.
Tan, Guan Hee, Dominik Deniffel, Antonio Finelli, et al.. (2023). Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance. Urologic Oncology Seminars and Original Investigations. 41(3). 146.e23–146.e28.
6.
Cheung, Douglas C., Lisa Martin, Maria Komisarenko, et al.. (2023). A Matched Analysis of Active Surveillance Versus Nephrectomy for T1a Small Renal Masses. European Urology Oncology. 6(5). 535–539. 7 indexed citations
7.
McAlpine, Kristen, Keith A. Lawson, Olli Saarela, et al.. (2023). Surgeon-level versus hospital-level quality variance in kidney cancer surgery. Urologic Oncology Seminars and Original Investigations. 41(5). 257.e7–257.e17. 2 indexed citations
8.
Ghosh, Sunita, Antonio Finelli, Lori Wood, et al.. (2023). Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System. JCO Global Oncology. 9(9). e2300271–e2300271. 1 indexed citations
9.
Ghai, Sangeet, Nathan Perlis, Katherine Lajkosz, et al.. (2022). Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Radiology. 305(2). 390–398. 22 indexed citations
10.
Ghai, Sangeet, Antonio Finelli, Rosanna Chan, et al.. (2021). MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Radiology. 298(3). 695–703. 44 indexed citations
11.
Phạm, Quỳnh, Jacqueline L. Bender, Alejandro Berlín, et al.. (2021). Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across Canada. BMJ Open. 11(4). e045806–e045806. 8 indexed citations
12.
Shiff, Benjamin, Rodney H. Breau, Ranjeeta Mallick, et al.. (2021). Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. Urologic Oncology Seminars and Original Investigations. 39(12). 836.e19–836.e27. 13 indexed citations
13.
Dong, Lei, Wei Xu, Dixon Woon, et al.. (2020). Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada. European Urology Open Science. 19. e1700–e1700. 2 indexed citations
14.
Couture, Félix, Antonio Finelli, Amélie Têtu, et al.. (2020). Management of complex renal cysts in Canada: results of a survey study. BMC Urology. 20(1). 4 indexed citations
15.
Goldberg, Hanan, Jaime O. Herrera‐Cáceres, Alejandro Berlín, et al.. (2020). Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass. Urologic Oncology Seminars and Original Investigations. 38(6). 603.e17–603.e25. 21 indexed citations
16.
Meo, Ashley Di, Ihor Batruch, Marshall Brown, et al.. (2019). Searching for prognostic biomarkers for small renal masses in the urinary proteome. International Journal of Cancer. 146(8). 2315–2325. 29 indexed citations
17.
Ahmad, Ardalan E., Bimal Bhindi, Patrick O. Richard, et al.. (2019). <p>Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis</p>. Cancer Management and Research. Volume 11. 10043–10050. 4 indexed citations
18.
Khella, Heba, Andreas Scorilas, Roy Nofech‐Mozes, et al.. (2017). miR-10b is a prognostic marker in clear cell renal cell carcinoma. Journal of Clinical Pathology. 70(10). 854–859. 31 indexed citations
19.
Sayyid, Rashid K., Andrew Evans, Karen Hersey, et al.. (2016). A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy. Clinical Cancer Research. 23(8). 1974–1980. 34 indexed citations
20.
Giangreco, Angeline A., Dennis Wagner, Antonio Finelli, et al.. (2013). Tumor Suppressor microRNAs, miR-100 and -125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue. Cancer Prevention Research. 6(5). 483–494. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Kane Breakdown of academic impact, for papers by Adam S. Kibel Breakdown of academic impact, for papers by Axel S. Merseburger Breakdown of academic impact, for papers by James M. McKiernan Breakdown of academic impact, for papers by Michael A.S. Jewett Breakdown of academic impact, for papers by Maxine Sun Breakdown of academic impact, for papers by Robert Huddart Breakdown of academic impact, for papers by Martin G. Sanda Breakdown of academic impact, for papers by Quoc‐Dien Trinh Breakdown of academic impact, for papers by Stacy Loeb
Rankless by CCL
2026